Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 2Thoracic 1Other 1Head & Neck 1

Conditions

Rectal Neoplasms 1Prevention of Colorectal Cancer 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 324Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Selenomethionine × Gastrointestinal × Clear all
NCT00625183 2017-11-17

Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma

Roswell Park Cancer Institute

Phase 2 Terminated
5 enrolled 6 charts
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT01211561 2010-09-29

Colon Cancer Prevention Using Selenium

University of Illinois at Chicago

Phase EARLY_PHASE1 Unknown
50 enrolled
Gastrointestinal

Prevention of Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡